Impairment of immunity to <i>Candida</i> and <i>Mycobacterium</i> in humans with bi-allelic <i>RORC</i> mutations

Satoshi Okada(Hiroshima University), Janet Markle(Rockefeller University), Elissa K. Deenick(Garvan Institute of Medical Research), Federico Mele(Università della Svizzera italiana), Diana Averbuch(Hadassah Academic College), Macarena Lagos(Hospital Padre Hurtado), Mohammed Alzahrani(King Faisal Specialist Hospital & Research Centre), Saleh Al‐Muhsen(King Faisal Specialist Hospital & Research Centre), Rabih Halwani(King Saud University), S. Cindy(Garvan Institute of Medical Research), Natalie Wong(Garvan Institute of Medical Research), Claire Soudais(Inserm), Lauren A. Henderson(Boston Children's Hospital), Hiyam Marzouqa(Herzog Hospital), Jamal Shamma(Herzog Hospital), Marcela González(University of Valparaíso), Rubén Martínez‐Barricarte(Rockefeller University), Chizuru Okada(Rockefeller University), Danielle T. Avery(Garvan Institute of Medical Research), Daniela Latorre(Università della Svizzera italiana), Caroline Deswarte(Inserm), Fabienne Jabot‐Hanin(Inserm), Egídio Torrado(Trudeau Institute), Jeffrey J. Fountain(Trudeau Institute), Aziz Belkadi(Inserm), Yuval Itan(Rockefeller University), Bertrand Boisson(Rockefeller University), Mélanie Migaud(Inserm), Cecilia S. Lindestam Arlehamn(La Jolla Institute for Immunology), Alessandro Sette(La Jolla Institute for Immunology), Sylvain Breton(Assistance Publique – Hôpitaux de Paris), James McCluskey(The University of Melbourne), Jamie Rossjohn(Australian Research Council), Jean‐Pierre de Villartay(Délégation Paris 5), Despina Moshous(Délégation Paris 5), Sophie Hambleton(Great North Children's Hospital), Sylvain Latour(Délégation Paris 5), Peter D. Arkwright(Royal Manchester Children's Hospital), Capucine Pïcard(Inserm), Olivier Lantz(Inserm), Dan Engelhard(Hadassah Academic College), Masao Kobayashi(Hiroshima University), Laurent Abel(Inserm), Andrea M. Cooper(Trudeau Institute), Luigi D. Notarangelo(Boston Children's Hospital), Stéphanie Boisson‐Dupuis(Inserm), Anne Puel(Inserm), Federica Sallusto(Università della Svizzera italiana), Jacinta Bustamante(Inserm), Stuart G. Tangye(Garvan Institute of Medical Research), Jean‐Laurent Casanova(Howard Hughes Medical Institute)
Science
July 9, 2015
Cited by 415Open Access
Full Text

Abstract

Human inborn errors of immunity mediated by the cytokines interleukin-17A and interleukin-17F (IL-17A/F) underlie mucocutaneous candidiasis, whereas inborn errors of interferon-γ (IFN-γ) immunity underlie mycobacterial disease. We report the discovery of bi-allelic RORC loss-of-function mutations in seven individuals from three kindreds of different ethnic origins with both candidiasis and mycobacteriosis. The lack of functional RORγ and RORγT isoforms resulted in the absence of IL-17A/F-producing T cells in these individuals, probably accounting for their chronic candidiasis. Unexpectedly, leukocytes from RORγ- and RORγT-deficient individuals also displayed an impaired IFN-γ response to Mycobacterium. This principally reflected profoundly defective IFN-γ production by circulating γδ T cells and CD4(+)CCR6(+)CXCR3(+) αβ T cells. In humans, both mucocutaneous immunity to Candida and systemic immunity to Mycobacterium require RORγ, RORγT, or both.


Related Papers

No related papers found

Powered by citation graph analysis